Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Competitive Triathletes Show Evidence of Myocardial Fibrosis

News Daily News

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Michael O'Riordan

December 25, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

October 29, 2017

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

News Daily News

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

October 24, 2017

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

News Daily News

3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort

Michael O'Riordan

July 11, 2017

Fusion Imaging for Valve Intervention: Must Have or Nice to Have?

Presentation TVT 2017

Fusion Imaging for Valve Intervention: Must Have or Nice to Have?

Presenter: Brian K. Whisenant, John D. Carroll

June 15, 2017

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

May 12, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.